Purple Biotech Reports First Quarter 2025 Financial Results
Provided By GlobeNewswire
Last update: May 21, 2025
Final CM24 Phase 2 data presented at AACR Annual Meeting 2025, strengthening patient selection strategy for CM24 Phase 2b study planned to be initiated in Second Half of 2025
Read more at globenewswire.com
